News

Gilead Sciences  announced that the China Food and Drug Administration(CFDA) has approved Sovaldi (sofosbuvir 400mg), a once-daily oral nucleotide analog polymerase inhibitor for the…
Read More...

In an effort to improve health outcomes of people with type 2 diabetes, Geisinger and Boehringer Ingelheim, on behalf of its diabetes alliance with Eli Lilly and Company announced a…
Read More...

Catalent announced it has reached an agreement to acquire Bloomington, Indiana-based Cook Pharmica LLC, an integrated provider of drug substance and drug product manufacturing and…
Read More...

Lung cancer patients in England can now be prescribed nivolumab, also known as Opdivo, after NICE says it should be available through the Cancer Drugs Fund (CDF). Around 1,300 lung…
Read More...

NICE is urging GPs to manage most common ear infections with pain relief rather than antibiotics. The draft guidance advises GPs and healthcare professionals how they should treat…
Read More...

Recipharm AB announces today that it has entered into collaboration with Roche and signed a long-term manufacturing agreement whereby Recipharm will manufacture a range of solid dose…
Read More...

To ensure patients and providers have access to important, lower cost biosimilar medicines, Pfizer filed suit in the U.S. District Court for the Eastern District of Pennsylvania against…
Read More...

Novartis announced that the European Commission (EC) approved Rydapt® (midostaurin) for two indications in rare, hard-to-treat cancers. Rydapt is approved for use in combination with…
Read More...

AVEO Oncology and EUSA Pharma announced that EUSA Pharma, under its multi-territory licensing agreement with AVEO for FOTIVDA (tivozanib), has opted into the Phase 1/2 TiNivo study.…
Read More...

Labcyte Inc. announced that GSK has joined its consortium with AstraZeneca to combine acoustic liquid dispensing technology from Labcyte with Mass Spectrometry (MS) for use in high…
Read More...

MilliporeSigma announced the opening of its first BioReliance End-to-End Biodevelopment Center in the Asia Pacific (APAC) region. Located in Shanghai, China, the center will provide a…
Read More...

Provention Bio announced that it has entered into agreements with Janssen Pharmaceutica NV and Janssen Sciences Ireland UC to in-license two clinical-stage assets, PRV-6527…
Read More...

Painful side effects from cancer medicines could be tackled with a drug that eases the effects of jetlag, research suggests. The drug – known as melatonin – appeared to prevent pain…
Read More...

AstraZeneca announced that it has entered into an agreement with Aspen Global Incorporated under which AGI will now acquire the residual rights to the established anaesthetic medicines…
Read More...

Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment. Scientists from the National University of Singapore (NUS) recently showed…
Read More...

Immunocore Limited announced an investment from the Bill & Melinda Gates Foundation to support the development of Immunocore's soluble TCR-based therapeutics for infectious…
Read More...

Regeneron Pharmaceuticals and Sanofi announced positive results from the Phase 3 CAFÉ study of DUPIXENT® (dupilumab) in adults with moderate-to-severe atopic dermatitis (AD) who are…
Read More...

Thrombolytic Science, LLC (TSI) announced the completion of a Phase 1 clinical trial of TS01, a new-generation clot-dissolving therapy aimed at the treatment of clot-induced diseases…
Read More...

Eurofins Scientific announces that it has signed an agreement to acquire EAG Laboratories from Odyssey Investment Partners. The transaction is expected to close in the next few months,…
Read More...

Absorption Systems announces a formal Research Collaboration Agreement (RCA) with the U.S. Food and Drug Administration (FDA). The goals are to improve the FDA's ability to predict…
Read More...